Information  X 
Enter a valid email address

Broker Forecast - JP Morgan Cazenove issues a broker note on Dechra Pharmaceuticals PLC

By BFN News | 11:10 AM | Friday 05 June, 2020


JP Morgan Cazenove today reaffirms its overweight investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and cut its price target to 3200p (from 3300p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk

a d v e r t i s e m e n t